Achieve your drug program goals with one integrated CDMO partner.
Expertise to accelerate and de-risk your drug product journey.
Start your next project with Upperton.
As a leading UK-based CDMO our defining traits lie in our adaptability, nimbleness and expertise in oral, nasal and pulmonary dosage forms.
Through our science-led approach we align to your drug development needs from pre-clinical to late phase manufacture, across oral solid dosage forms, liquids, semi-solids, nasal and inhaled products.
Science-led expertise providing you with unparalleled project delivery.
Our team support you at each stage of your drug program lifecycle from pre-clinical to market.
Our CDMO services include formulation development, phase 1, phase 2 and phase 3 clinical supply, process scale-up and optimisation, quality control, analytical development and validation, and registration activities.
Nottingham, UK
An award-winning facility
built to meet your patient targets.
Our award-winning 50,000 sqft development and manufacturing facility, Trent Gateway, enables our teams to be flexible and nimble so that we can problem-solve, meet your timescales, and deliver solutions that meet patient targets.
Speak with our Experts
Get in touch to start a discovery call with our team and accelerate your drug program journey with Upperton.
